Hepcidin-25 among Patients Undergoing Conventional and Extended-hours Hemodialysis; An Inverse Probability of Treatment Weighting Analysis Using Propensity Scores

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 


 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/5d06fe9f401f08134752db4aa1861636.pdf
Hepcidin-25 among Patients Undergoing Conventional and Extended-hours Hemodialysis; An Inverse Probability of Treatment Weighting Analysis Using Propensity Scores

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Nobuhiro
Nishibori
Nobuhiro Nishibori bori6314@outlook.jp Nagoya University Graduate School of Medicine Nephrology Nagoya Japan *
Masaki Okazaki ausn76219@gmail.com Nagoya University Graduate School of Medicine Nephrology Nagoya Japan -
Hiroshi Seko seko0913@gmail.com Nagoya University Graduate School of Medicine Nephrology Nagoya Japan -
Shigefumi Ishikawa ishikawa27@med.nagoya-u.ac.jp Nagoya University Graduate School of Medicine Nephrology Nagoya Japan -
Takahiro Imaizumi imaizumi.takahiro.r7@f.mail.nagoya-u.ac.jp Nagoya University Graduate School of Medicine Clinical Research Education Nagoya Japan -
Takumi Yamada yamada.takumi.s3@s.mail.nagoya-u.ac.jp Nagoya University Graduate School of Medicine Nephrology Nagoya Japan -
Manabu Hishida spulse5120@yahoo.co.jp Kaikoukai Josai Hospital Nephrology Nagoya Japan -
Ryosuke Ishikawa ishikawa.r1@med.nagoya-u.ac.jp Nagoya University Graduate School of Medicine Nephrology Nagoya Japan -
Yoshihiro Nakamura nakamurashift7@gmail.com Nagoya University Graduate School of Medicine Nephrology Nagoya Japan -
Shimon Kurasawa kurasawa.shimon.w8@f.mail.nagoya-u.ac.jp Nagoya University Graduate School of Medicine Nephrology Nagoya Japan -
Toru Kondo kondo.toru.v2@f.mail.nagoya-u.ac.jp Nagoya University Graduate School of Medicine Cardiology Nagoya Japan -
Yuhei Otobe otobeyuhei@gmail.com Osaka Metropolitan University 5) Graduate School of Rehabilitation Science Osaka Japan -
Hirotake Kasuga hkasuga@kaikou.or.jp Nagoya Kyoritsu Hospital Nephrology Nagoya Japan -
Fumika Kaneda f.kaneda@kamome-clinic.com Kamome Otsuko Clinic Nephrology Kitaibaraki Japan -
Shoichi Maruyama maruyama.shoichi.y5@f.mail.nagoya-u.ac.jp Nagoya University Graduate School of Medicine Nephrology Nagoya Japan -

In patients on maintenance hemodialysis (HD), elevated interleukin 6 (IL-6) levels promote hepcidin synthesis and cause anemia due to impaired iron utilization. Extended-hours HD has been suggested to reduce erythropoietin dosage by improving iron utilization efficiency; however, the association of extended-hours HD with hepcidin remains unclear. The aim of this study is to investigate the association of extended-hours HD with hepcidin, and to assess its subsequent effects on iron metabolism.

Patients on extended-hours or conventional HD between January and March 2020 were included in the study. Hepcidin-25 and IL-6 levels were measured from pre-dialysis samples. Multivariable linear regression analysis was performed to investigate the impact of extended-hours HD on hepcidin-25 and iron metabolism–serum ferritin levels and transferrin saturation (TSAT). Subsequently, mediation analysis was conducted to evaluate the mediating effects of iron metabolism and hepcidin-25, respectively. To minimize the impact of differences in target values for iron metabolism markers across dialysis modalities, propensity score (PS)–inverse probability weighting (IPW) analysis was conducted as a sensitivity analysis. PS were estimated using age, sex, dialysis vintage, iron supplementation, presence of dyslipidemia, log-transformed (ln-) ferritin and ln-TSAT. Restricted cubic spline (RCS) curves were used to evaluate the non-linear associations between hepcidin-25 and ferritin, TSAT, and IL-6, and interactions with extended-hours HD were tested using Wald’s tests.

Table 1_Linear regression analysis, with extended-hours HD as the explanatory variable.Fig1_Differences in IL6 and hepcidin25 between extended hours HD and conventional HD groupsA total of 380 participants (183 on extended-hours HD and 197 on conventional HD) were included in the analysis. The median ferritin and TSAT levels were 35.3 ng/dL and 16.9 %, respectively, in extended-hours HD group, and 63.8 ng/dL and 20.5%, respectively, in conventional HD group. Extended-hours HD was associated with lower hepcidin-25 levels compared to conventional HD, despite similar IL-6 levels (Figure 1A, B). Extended-hours HD was associated with lower ln-hepcidin-25; -0.57 (95% confidence interval (CI); -0.85 to -0.28), and 35% of this association was mediated by ln-ferritin (P <0.01). Before adjustment for hepcidin-25, extended-HD was significantly associated with lower ln-ferritin; -0.43 (95% CI; -0.62 to -0.23); however, this association was fully mediated by ln-hepcidin-25 (total mediation proportion was 69%). Extended-hours HD was not significantly associated with lower ln-TSAT (Table 1). For the fit of PS analysis, the C-statistics of logistic regression analysis for PS was 0.80, and absolute standardized difference values were less than 0.1 for all covariates. In the PS-IPW analysis, the association between extended-hours HD and hepcidin-25 remained similar. Using the RCS function, extended-hours HD was associated with lower hepcidin-25 levels compared to conventional HD, independently of iron metabolism. The analysis also suggested that, in extended-hours HD, the increase in hepcidin-25 in response to elevated IL-6 levels was attenuated (Figure 2A, B, C).

Extended-hours HD was associated with lower hepcidin-25 levels independently of iron supplementation, ferritin, and TSAT, even after PS-IPW analysis. These results were suggested that extended-hours HD might improve iron utilization by suppressing the hepcidin-25 response to elevated IL-6 levels.

Kewords